Statins can benefit patients with primary membranous nephropathy on venous thromboembolism
Objective The aim of this study was to investigate the role of prophylactic use of statin in venous thromboembolism (VTE) in patients with primary membranous nephropathy (PMN). Methods A total of 734 patients with PMN were consecutively enrolled in this retrospective study. 564 patients had received...
Main Authors: | Peimei Zou, Hang Li, Jianfang Cai, Zhenjie Chen, Chao Li, Xuewang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/0886022X.2021.1879853 |
Similar Items
-
The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
by: Peimei Zou, et al.
Published: (2019-01-01) -
The role of dyslipidemia and statins in venous thromboembolism
by: Rosendaal Frits R, et al.
Published: (2001-07-01) -
Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry
by: Nicolas Henry, et al.
Published: (2020-09-01) -
Preventing venous thromboembolism without causing harm
by: Aaron B Holley
Published: (2021-01-01) -
Venous Thromboembolism Following Travel
by: Morteza Izadi, et al.
Published: (2014-03-01)